Results

Total Results: 1,269 records

Showing results for "author year description".

101. Disposition of Comments for CER 211: Drug Therapy for Early Rheumatoid Arthritis: A Systematic Review Update (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/cer-211-rheumatoid-arthritis-disposition-comments.pdf
     December 20, 2018 - We have added more description surround the context of the definition in the introduction. … Peer Reviewer #1 Methods Description of Data synthesis and network MA is clear. … We add this description to the Methods text under “Data Synthesis” and each radiographic forest plot … There was no description provided for switching to frequentist method or justification for random or … Peer Reviewer #1 Results Page 70: please make sure the description of results to be accurate and

102. Making Healthcare Safer IV_Rapid Response_Deprescribing To Reduce Medication Harms in Older Adults (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/mhs-IV-rapid-response-deprescribing.pdf
     February 01, 2024 - intervention Studies focused on medication reconciliation only Comparator Usual practice No clear description … Characteristics of included systematic reviews Type of review Author, Year # Studies Types of … Characteristics of included original studies Author, Year Study Design Setting Population Sample … ROBINS-I risk of bias assessment for nonrandomized studies Author, year Confounding Selection … Cochrane Risk of Bias for RCTs Author, Year Random Allocation Concealment Blinding Participants

103. ambulatory-safety-protocol-150724 (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/ambulatory-safety_research-protocol.pdf
     July 24, 2015 - for the Technical Brief The Agency for Healthcare Research and Quality (AHRQ) is launching a multi-year … initiative in Fiscal Year 2015 to expand the scientific evidence, strategies, and tools that are available … Searches will begin with the year 2000. … dual abstraction of study-level details based on the previous MHCS review, including intervention description … Amendments In the event of protocol amendments, the date of each amendment will be accompanied by a description

104. Comparative Effectiveness of Treatment for Open-Angle Glaucoma | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/products/glaucoma-treatment/research-protocol
     December 01, 2019 - Description of the Condition Glaucoma is a leading cause of visual impairment and blindness worldwide … A detailed description of Food and Drug Administration (FDA) approval status, indications, and warnings … Timing Outcomes will be assessed at 1 year of follow-up and at annual intervals thereafter. … Comparison of treatment outcomes within race: 10-year results. Ophthalmology 2004;111:651-64. … Amendments In the event of protocol amendments, the date of each amendment will be accompanied by a description

105. Making Healthcare Safer IV_Rapid Review_Healthcare Worker Implicit Bias Training and Education (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/mhs-IV-rapid-review-implicit-bias.pdf
     January 01, 2024 - Primary study characteristics Author, Year Country Study Design HCW Characteristics Patient … pressure, HbA1c 18 Making Healthcare Safer IV – Implicit Bias Training and Education Author … Primary study results and quality Author, Year Results Quality Appraisal(s) Majumdar, 200446 No … RoB2-CRT for RCTs 23 Making Healthcare Safer IV – Implicit Bias Training and Education Author … This report is made available to the public under the terms of a licensing agreement between the author

106. Disposition of Comments Report for Oral Contraceptive Use for the Primary Prevention of Ovarian Cancer (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/cancer-ovarian-contraceptives_disposition-comments.pdf
     June 07, 2013 - Please reword to provide a more detailed description We have revised the sentence to be more precise … primary focus was on the association between OC use and ovarian cancer, we chose a less restrictive year … compared to the other cancers of interest, we analyzed the results with both a more and less restrictive year … Would it be possible/helpful to stratify the 0-10 year interval into 2 intervals? … The reviewer is correct, and we have revised this description to clarify that probabilistic analysis

107. Improving Health Care and Palliative Care for Advanced and Serious Illness Disposition of Comments Report (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/quality-gap-palliative-hospice_disposition-comments.pdf
     October 01, 2012 - We have also added this as a further description of the heterogeneity in the pain section: “Moreover … There is no reference provided for this specific year. … year as 2010). … More description of the studies - including why it is counted as QI study. … We have clarified in a footnote that the different author studies are actually different publications

108. Topic Brief: Accelerated Partial Breast Irradiation for Breast Cancer (pdf file)
     effectivehealthcare-admin.ahrq.gov/system/files/docs/topic-brief-apbi-breast-cancer.pdf
     August 01, 2022 - Author Emily Gean Conflict of Interest: None of the investigators have any affiliations or financial … The findings and conclusions in this document are those of the author(s) who are responsible for its … See Appendix B for detailed description of the criteria. … effectivehealthcare.ahrq.gov/sites/default/files/webform/docs/APBI%202017%20Guidelin e.pdf Title or short description … References Author Impact of a New Evidence Review Yes.

109. Registry of Patient Registries (RoPR): Project Overview | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/products/registry-of-patient-registries/research-2012-3
     December 01, 2019 - Patient Registries Developing a Web-based Forum Developing a Registry of Patient Registries Author … data element sections identified by stakeholders for describing a RoPR registry record: Registry Description—identification … and description information.

110. Atrial-Fibrillation-Ablation Surveillance (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/atrial-fibrillation-ablation_surveillance.pdf
     May 16, 2013 - Cycle 1 (1st assessment) In total, 4 CER-specific (e.g., lead author, clinical content experts, and … Based on the study description, we surmised that most of the adverse events either took place in a … . 319 (32%), p=0.005 Source: www.effectivehealthcare.ahrq.gov Published online: May 16, 2013 Author … 14/61 (23%), p=0.001 Source: www.effectivehealthcare.ahrq.gov Published online: May 16, 2013 Author … PV NA Complications Source: www.effectivehealthcare.ahrq.gov Published online: May 16, 2013 Author

111. Disclosure Policy and Form (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/epc-disclosure-policy-form.pdf
     March 01, 2023 - For example, if financial COI from all sources over a two year time window (within the past year and … Institution on Your Behalf Your Spouse/ Children's Income or Assets Name of Equity and description … Institution on Your Behalf Your Spouse/ Children's Income or Assets Name of Equity and description … For example, if financial COI from all sources over a two year time window (within the past year and … For example, if financial COI from all sources over a two year time window (within the past year and

112. Documentation Burden | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/products/documentation-burden/protocol
     September 01, 2023 - Guiding Questions Description/Overview of measurements of documentation burden: … We will limit the literature search to studies published after the year 2000. Table 1. … Information Management We will develop a standardized data extraction form to extract study characteristics (author … , year, study design, inclusion and exclusion criteria, study settings, population, metric of documentation … In the event of protocol amendments, the date of each amendment will be accompanied by a description

113. Evidence Map on Home and Community Based Services (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/evidence-map-hcbs-protocol.pdf
     July 27, 2023 - We plan to include studies published after the year 2000 and studies conducted in the United States. … Registrar of Controlled Trials, Ovid® Cochrane Database of Systematic Reviews, and Scopus® from the year … We will limit the literature to studies published in English and published after the year 2000. … Information Management We will develop a standardized data extraction form to extract study characteristics (author … Amendments In the event of protocol amendments, the date of each amendment will be accompanied by a description

114. Evidence Report No. 222, Data Linkage Strategies To Advance Youth Suicide Prevention (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/suicide-prevention_research.pdf
     October 01, 2016 - § See Table 1 for the full PICOTS description. … Summary of intervention characteristics Program or Study Name (If Applicable) Author, Year Intervention … Summary of intervention characteristics (continued) Program or Study Name (if applicable) Author, Year … Summary of intervention characteristics (continued) Program or Study Name (if applicable) Author, Year … x 6 Year Data Collection Started 3 date (YYYY) x 6 Year Data Collection Stopped 3 date (YYYY

115. Disposition of Comments Report for Chronic Venous Ulcers: A Comparative Effectiveness Review of Treatment Modalities (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/venous-ulcers-treatment_disposition-comments.pdf
     January 27, 2014 - Characteristics” for Key Question 1, we report that “the median age of patients was between 60 and 70 year … Peer Reviewer#1 Introduction The description needs to be clarified regarding the clinical indications … Peer Reviewer#1 Methods There is no description of whether or not the authors included grey literature … An explanation of how pain was evaluated is included in each study description. … than compression alone, especially for ulcers that had failed therapy and were present for over 1 year

116. Evidence-based Practice Center Systematic Review Protocol (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/cerebral-palsy-feeding_research-protocol.pdf
     June 12, 2012 - Data suggest that during the first year of life, 57 percent of children with CP have sucking problems … evidence table may vary by KQ as appropriate, but the tables will contain some common elements, such as author … , year of publication, population and intervention descriptions, sample size, key outcomes, and study … Prevalence of cerebral palsy among ten-year-old children in metropolitan Atlanta, 1985 through 1987. … A priori' methods of assessment should be provided (e.g., for effectiveness studies if the author(s

117. Disposition of Comments for Evidence Report 224 Omega-3 Fatty Acids (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/omega-3-maternity_disposition-comments.pdf
     October 12, 2016 - Perhaps a brief description of the methodology to quantitate omega-3 levels for the included studies … have added it to the description of the findings of this study. … Author name “van Goor”-this study is presented in the tables twice, pg 132 & pg 133-134 Pg 170 line … We have made every effort to be transparent in our description of our methods and decisions. … Customarily, update searches commence with the publication year one year prior to the latest search

118. Glaucoma-Treatment Research-Protocol (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/glaucoma-treatment_research-protocol.pdf
     November 16, 2010 - Description of the condition Glaucoma is a leading cause of visual impairment and blindness worldwide … A detailed description of Food and Drug Administration (FDA) approval status, indications, and warnings … Death Description of Key Question 5 Key Question 5 explores the association of 1) lowering intraocular … Timing Outcomes will be assessed at 1 year of follow-up and at annual intervals thereafter. … Comparison of treatment outcomes within race: 10-year results. Ophthalmology 2004;111:651-64.

119. Pharmacologic and Nonpharmacologic Treatments for Posttraumatic Stress Disorder: 2022 Update of the PTSD-Repository Evidence Base (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/ptsd-dispositIon-comments-2022.pdf
     January 01, 2022 - Published Online: October 24, 2022 2 Peer Reviewer, Technical Expert, and Public Comments and Author … Figure 7-consider footnoting the Year 2021 since the data for it are only for part of the year. … First, the title should probably indicate that the unit of description (i.e. row) here is treatment … Commentator & Affiliation Section Comment Response Peer Reviewer #5 General The report is a description … from a total of 427) the question is -are there studies that are close to completion where waiting a year

120. Microsoft Word - 3-DKE274__ACEI-ARB-DRI__Comments_Disposition_Table-21_Jan_2011 cyk _2_.docx (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/ace-inhibitor-arb-update_disposition-comments.pdf
     October 07, 2011 - Executive Summary There is an incorrect description of the Renin-Angiotensin Aldosterone System ( … The description has been corrected and now matches the main report. … meaningful way (e.g., all the RCTs together, all the observational studies together, and then sorted by year … re-formatted the figures and tables to list RCTs and observational studies together in a group and then by year … Rather than having readers find the original GRADE papers, a very brief description of the relevant